Ketones Step to the Plate: A Game Changer for Metabolic Remodeling in Heart Failure?
- PMID: 26819375
- PMCID: PMC4826559
- DOI: 10.1161/CIRCULATIONAHA.116.021230
Ketones Step to the Plate: A Game Changer for Metabolic Remodeling in Heart Failure?
Keywords: Editorials; heart failure; hypertrophy; metabolism.
Figures

Comment on
-
Evidence for Intramyocardial Disruption of Lipid Metabolism and Increased Myocardial Ketone Utilization in Advanced Human Heart Failure.Circulation. 2016 Feb 23;133(8):706-16. doi: 10.1161/CIRCULATIONAHA.115.017545. Epub 2016 Jan 27. Circulation. 2016. PMID: 26819374 Free PMC article.
-
The Failing Heart Relies on Ketone Bodies as a Fuel.Circulation. 2016 Feb 23;133(8):698-705. doi: 10.1161/CIRCULATIONAHA.115.017355. Epub 2016 Jan 27. Circulation. 2016. PMID: 26819376 Free PMC article.
Similar articles
-
Heart failure: Ketone bodies as fuel in heart failure.Nat Rev Cardiol. 2016 Mar;13(3):122-3. doi: 10.1038/nrcardio.2016.22. Epub 2016 Feb 11. Nat Rev Cardiol. 2016. PMID: 26864914 No abstract available.
-
Cardiac ketone body metabolism.Biochim Biophys Acta Mol Basis Dis. 2020 Jun 1;1866(6):165739. doi: 10.1016/j.bbadis.2020.165739. Epub 2020 Feb 19. Biochim Biophys Acta Mol Basis Dis. 2020. PMID: 32084511 Review.
-
The Failing Heart Relies on Ketone Bodies as a Fuel.Circulation. 2016 Feb 23;133(8):698-705. doi: 10.1161/CIRCULATIONAHA.115.017355. Epub 2016 Jan 27. Circulation. 2016. PMID: 26819376 Free PMC article.
-
Evidence for Intramyocardial Disruption of Lipid Metabolism and Increased Myocardial Ketone Utilization in Advanced Human Heart Failure.Circulation. 2016 Feb 23;133(8):706-16. doi: 10.1161/CIRCULATIONAHA.115.017545. Epub 2016 Jan 27. Circulation. 2016. PMID: 26819374 Free PMC article.
-
Implications of Altered Ketone Metabolism and Therapeutic Ketosis in Heart Failure.Circulation. 2020 Jun 2;141(22):1800-1812. doi: 10.1161/CIRCULATIONAHA.119.045033. Epub 2020 Jun 1. Circulation. 2020. PMID: 32479196 Free PMC article. Review.
Cited by
-
Empagliflozin reduces myocardial ketone utilization while preserving glucose utilization in diabetic hypertensive heart disease: A hyperpolarized 13 C magnetic resonance spectroscopy study.Diabetes Obes Metab. 2019 Feb;21(2):357-365. doi: 10.1111/dom.13536. Epub 2018 Oct 18. Diabetes Obes Metab. 2019. PMID: 30225964 Free PMC article.
-
β-Hydroxybutyrate in Cardiovascular Diseases : A Minor Metabolite of Great Expectations.Front Mol Biosci. 2022 Jun 13;9:823602. doi: 10.3389/fmolb.2022.823602. eCollection 2022. Front Mol Biosci. 2022. PMID: 35769904 Free PMC article. Review.
-
E2F6 Impairs Glycolysis and Activates BDH1 Expression Prior to Dilated Cardiomyopathy.PLoS One. 2017 Jan 13;12(1):e0170066. doi: 10.1371/journal.pone.0170066. eCollection 2017. PLoS One. 2017. PMID: 28085920 Free PMC article.
-
Sodium-glucose cotransporter 2 inhibitors represent a paradigm shift in the prevention of heart failure in type 2 diabetes patients.J Diabetes Investig. 2021 Jan;12(1):6-20. doi: 10.1111/jdi.13329. Epub 2020 Aug 5. J Diabetes Investig. 2021. PMID: 32563214 Free PMC article. Review.
-
Metabolic Reprogramming After Left Ventricular Assist Device: Remodeling Without Recovery of Cardiac Energetics.JACC Basic Transl Sci. 2016 Oct 31;1(6):445-448. doi: 10.1016/j.jacbts.2016.09.003. eCollection 2016 Oct. JACC Basic Transl Sci. 2016. PMID: 30167531 Free PMC article.
References
-
- Ingwall JS, Weiss RG. Is the failing heart energy starved? On using chemical energy to support cardiac function. Circ Res. 2004;95:135–145. - PubMed
-
- Neubauer S. The failing heart--an engine out of fuel. N Engl J Med. 2007;356:1140–1151. - PubMed
-
- Fukushima A, Milner K, Gupta A, Lopaschuk GD. Myocardial energy substrate metabolism in heart failure : From pathways to therapeutic targets. Curr Pharm Des. 2015;21:3654–3664. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical